Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a personalized plan to help people with sleep apnea keep using their treatment

Tests a personalized program helping adults with sleep apnea stick to their breathing device.

Plain-language title generated from the registry record
Registry title: Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

Key facts

Where
Miami, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 55 and 85 years old?

Source: NCT06089161, who can take part

Where in United States

  • University of MiamiMiami, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Miami
Trial code
NCT06089161
Record updated
20 October 2026
Original description
The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).Read full original descriptionShow less

Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks

The purpose of this research is to see how effective the Personalized obstructive sleep apnea (OSA) Treatment Adherence Model called PRAISE is in helping the patient stick to the physician recommended OSA treatment plan Positive Airway Pressure (PAP).

Inclusion: Self-reported race/ethnicity as African American, African, Afro-latino, Caribbean or black; Ages 55-85 years; accessible by phone; OSA diagnosis; consent, including permission to release medical data.

Exclusion: progressive illnesses in which disability or death is expected within 1 year; impaired cognitive/ functional ability precluding participation; intention to move within the year; and a family member currently enrolled.

ClinicalTrials.gov NCT06089161